

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.32216532 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.32216532 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.79165332 |
| 4 | response to type I interferon (GO:0034340) | 5.76959537 |
| 5 | type I interferon signaling pathway (GO:0060337) | 5.75703010 |
| 6 | cellular response to type I interferon (GO:0071357) | 5.75703010 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.46789780 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 5.03676241 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.83061582 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 4.82604273 |
| 11 | detection of other organism (GO:0098543) | 4.54252209 |
| 12 | response to interleukin-15 (GO:0070672) | 4.51309378 |
| 13 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.49740874 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 4.48249992 |
| 15 | cellular response to interleukin-15 (GO:0071350) | 4.38973421 |
| 16 | detection of bacterium (GO:0016045) | 4.38377806 |
| 17 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.37078279 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.33102454 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 4.33102454 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.33102454 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.33102454 |
| 22 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.33102454 |
| 23 | modulation by symbiont of host immune response (GO:0052553) | 4.33102454 |
| 24 | T cell migration (GO:0072678) | 4.22474737 |
| 25 | response to interferon-alpha (GO:0035455) | 4.20199516 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 4.12636581 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.04231347 |
| 28 | activated T cell proliferation (GO:0050798) | 4.02809449 |
| 29 | cellular response to interferon-beta (GO:0035458) | 4.00679956 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 4.00346113 |
| 31 | cellular extravasation (GO:0045123) | 3.91121880 |
| 32 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.90414946 |
| 33 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.89051177 |
| 34 | negative regulation of viral genome replication (GO:0045071) | 3.88662799 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.87192844 |
| 36 | microglial cell activation (GO:0001774) | 3.81845611 |
| 37 | response to interferon-beta (GO:0035456) | 3.80964278 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.78586789 |
| 39 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.78424045 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.75984723 |
| 41 | detection of molecule of bacterial origin (GO:0032490) | 3.73499531 |
| 42 | * positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.72396871 |
| 43 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70155595 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.68539934 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.67458429 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.64683548 |
| 47 | negative thymic T cell selection (GO:0045060) | 3.64284549 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62776189 |
| 49 | cellular response to interferon-gamma (GO:0071346) | 3.62415080 |
| 50 | negative T cell selection (GO:0043383) | 3.62242218 |
| 51 | regulation of RIG-I signaling pathway (GO:0039535) | 3.62166995 |
| 52 | positive regulation of interferon-beta production (GO:0032728) | 3.57458184 |
| 53 | cellular response to virus (GO:0098586) | 3.55593139 |
| 54 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.55105398 |
| 55 | response to peptidoglycan (GO:0032494) | 3.54974319 |
| 56 | defense response to protozoan (GO:0042832) | 3.53320277 |
| 57 | leukocyte aggregation (GO:0070486) | 3.51979846 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.51974336 |
| 59 | B cell mediated immunity (GO:0019724) | 3.50820420 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.50621038 |
| 61 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.48318441 |
| 62 | B cell receptor signaling pathway (GO:0050853) | 3.46699161 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.45133285 |
| 64 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.44986121 |
| 65 | regulation of response to interferon-gamma (GO:0060330) | 3.44125210 |
| 66 | positive regulation of humoral immune response (GO:0002922) | 3.43919338 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43565762 |
| 68 | cellular response to interferon-alpha (GO:0035457) | 3.42848839 |
| 69 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41557084 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.41367259 |
| 71 | tolerance induction (GO:0002507) | 3.41285387 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.39993446 |
| 73 | detection of biotic stimulus (GO:0009595) | 3.38609886 |
| 74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38593536 |
| 75 | negative regulation of cell killing (GO:0031342) | 3.38593536 |
| 76 | regulation of regulatory T cell differentiation (GO:0045589) | 3.38197863 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.37286937 |
| 78 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.37275449 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.37275449 |
| 80 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.36648512 |
| 81 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35266001 |
| 82 | neutrophil mediated immunity (GO:0002446) | 3.34548617 |
| 83 | T-helper 1 type immune response (GO:0042088) | 3.33038830 |
| 84 | myeloid cell activation involved in immune response (GO:0002275) | 3.32630198 |
| 85 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.31771326 |
| 86 | regulation of B cell differentiation (GO:0045577) | 3.31513019 |
| 87 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.31182997 |
| 88 | myeloid dendritic cell differentiation (GO:0043011) | 3.29731613 |
| 89 | regulation of antigen processing and presentation (GO:0002577) | 3.29397902 |
| 90 | respiratory burst (GO:0045730) | 3.29382566 |
| 91 | response to protozoan (GO:0001562) | 3.27655569 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24218894 |
| 93 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.23974394 |
| 94 | macrophage activation (GO:0042116) | 3.23472864 |
| 95 | interferon-gamma production (GO:0032609) | 3.23295525 |
| 96 | dendritic cell migration (GO:0036336) | 3.22087675 |
| 97 | negative regulation of innate immune response (GO:0045824) | 3.20600190 |
| 98 | response to interferon-gamma (GO:0034341) | 3.18761562 |
| 99 | myeloid dendritic cell activation (GO:0001773) | 3.18756886 |
| 100 | response to host immune response (GO:0052572) | 3.18070093 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.18070093 |
| 102 | dendritic cell chemotaxis (GO:0002407) | 3.18051909 |
| 103 | cellular response to exogenous dsRNA (GO:0071360) | 3.16505112 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 3.14830177 |
| 105 | positive regulation of interleukin-12 production (GO:0032735) | 3.14727017 |
| 106 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.14476614 |
| 107 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.14083072 |
| 108 | interferon-gamma secretion (GO:0072643) | 3.12732768 |
| 109 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11763213 |
| 110 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.11026047 |
| 111 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.10720597 |
| 112 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.10720597 |
| 113 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.09802264 |
| 114 | positive thymic T cell selection (GO:0045059) | 3.09747781 |
| 115 | regulation of tolerance induction (GO:0002643) | 3.06263863 |
| 116 | myeloid leukocyte mediated immunity (GO:0002444) | 3.05184847 |
| 117 | defense response to virus (GO:0051607) | 3.03099568 |
| 118 | macrophage activation involved in immune response (GO:0002281) | 3.02200654 |
| 119 | granulocyte activation (GO:0036230) | 3.00559519 |
| 120 | positive regulation of B cell mediated immunity (GO:0002714) | 3.00395225 |
| 121 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.00395225 |
| 122 | negative regulation of adaptive immune response (GO:0002820) | 2.99972339 |
| 123 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.98878617 |
| 124 | natural killer cell mediated immunity (GO:0002228) | 2.98878617 |
| 125 | positive regulation of B cell differentiation (GO:0045579) | 2.98753559 |
| 126 | leukocyte degranulation (GO:0043299) | 2.98135198 |
| 127 | lymphocyte chemotaxis (GO:0048247) | 2.97096653 |
| 128 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.96989421 |
| 129 | regulation of mast cell activation (GO:0033003) | 2.96961004 |
| 130 | cytidine metabolic process (GO:0046087) | 2.96074170 |
| 131 | cytidine catabolic process (GO:0006216) | 2.96074170 |
| 132 | cytidine deamination (GO:0009972) | 2.96074170 |
| 133 | positive T cell selection (GO:0043368) | 2.95991241 |
| 134 | positive regulation of interleukin-17 production (GO:0032740) | 2.94695503 |
| 135 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.93316239 |
| 136 | neutrophil activation (GO:0042119) | 2.92686598 |
| 137 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.88809123 |
| 138 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.88540336 |
| 139 | thymic T cell selection (GO:0045061) | 2.88361096 |
| 140 | regulation of hypersensitivity (GO:0002883) | 2.88153721 |
| 141 | T cell selection (GO:0045058) | 2.87293588 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.86908433 |
| 143 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86812904 |
| 144 | response to host (GO:0075136) | 2.86812904 |
| 145 | response to host defenses (GO:0052200) | 2.86812904 |
| 146 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.86246728 |
| 147 | positive regulation of isotype switching (GO:0045830) | 2.84666622 |
| 148 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.84478108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.70989140 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.13223325 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.90088631 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.30082788 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.08648171 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.89425196 |
| 7 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.84202742 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.72595759 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.33964353 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.29097308 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22440699 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16017511 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04222870 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.80876377 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.78006752 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49278766 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46817341 |
| 18 | * MYB_26560356_Chip-Seq_TH2_Human | 2.30822554 |
| 19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26274203 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26273722 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.20847611 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17596835 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06788409 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.98391985 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 1.97092077 |
| 26 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94120523 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93837405 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88969356 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88148413 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81007729 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72326733 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71559715 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66231033 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65090576 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.62461204 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62336239 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53973735 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52205478 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51061027 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.50834751 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47037940 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46771237 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45523082 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42396688 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41411800 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.39639836 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.38408570 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37230384 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37055838 |
| 50 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35863181 |
| 51 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32967393 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29603879 |
| 53 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.27962835 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26438828 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26082724 |
| 56 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24203573 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24147699 |
| 58 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.22975112 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21083181 |
| 60 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20310025 |
| 61 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.19172197 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17367392 |
| 63 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12789878 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10132871 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09608311 |
| 66 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.09207711 |
| 67 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07251191 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.06996489 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06566534 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05310885 |
| 71 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.05226432 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05094976 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05083151 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04582881 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04327858 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01423765 |
| 77 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99416908 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98995397 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98039556 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97087078 |
| 81 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96772690 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94311188 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92885379 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91158174 |
| 85 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90905781 |
| 86 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90899713 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89539397 |
| 88 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87373961 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86609128 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86122358 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86121362 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.85762259 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85369595 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82730748 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82188429 |
| 96 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81957772 |
| 97 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80316322 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80191470 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79467865 |
| 100 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.79291581 |
| 101 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.77968019 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77963929 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77783161 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77600715 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75899900 |
| 106 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75735098 |
| 107 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.74540909 |
| 108 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73261414 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.72319512 |
| 110 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71865081 |
| 111 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.70097805 |
| 112 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.69918037 |
| 113 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.69459574 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69178913 |
| 115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67249442 |
| 116 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.66488206 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.65825270 |
| 118 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.64757250 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.62175421 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62085848 |
| 121 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61880906 |
| 122 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60455080 |
| 123 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.59374229 |
| 124 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.58377964 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 0.58263616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.81737910 |
| 2 | MP0009785_altered_susceptibility_to | 4.00521211 |
| 3 | MP0005671_abnormal_response_to | 3.52689806 |
| 4 | MP0003436_decreased_susceptibility_to | 3.45842139 |
| 5 | MP0000685_abnormal_immune_system | 3.40376145 |
| 6 | MP0005387_immune_system_phenotype | 3.28204647 |
| 7 | MP0001790_abnormal_immune_system | 3.28204647 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.18159168 |
| 9 | MP0003724_increased_susceptibility_to | 3.16645534 |
| 10 | MP0006082_CNS_inflammation | 3.15840461 |
| 11 | MP0005025_abnormal_response_to | 3.12407122 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 3.08187506 |
| 13 | MP0001800_abnormal_humoral_immune | 2.96753347 |
| 14 | MP0004510_myositis | 2.83177299 |
| 15 | MP0003303_peritoneal_inflammation | 2.77340876 |
| 16 | MP0002723_abnormal_immune_serum | 2.74432743 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.72593347 |
| 18 | MP0002419_abnormal_innate_immunity | 2.68823651 |
| 19 | MP0001819_abnormal_immune_cell | 2.48559976 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.46254492 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.38701597 |
| 22 | MP0004947_skin_inflammation | 2.32531353 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.28996960 |
| 24 | MP0002006_tumorigenesis | 2.14976497 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.08178396 |
| 26 | MP0002405_respiratory_system_inflammati | 2.02312591 |
| 27 | MP0002398_abnormal_bone_marrow | 1.96660282 |
| 28 | MP0000716_abnormal_immune_system | 1.96085032 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.94662197 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.93063238 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.92445667 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.87005571 |
| 33 | MP0001853_heart_inflammation | 1.83592057 |
| 34 | MP0008469_abnormal_protein_level | 1.76596895 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.74677054 |
| 36 | MP0005310_abnormal_salivary_gland | 1.73814727 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.71553359 |
| 38 | MP0009764_decreased_sensitivity_to | 1.68451815 |
| 39 | MP0003448_altered_tumor_morphology | 1.62611296 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.59571977 |
| 41 | MP0009840_abnormal_foam_cell | 1.57661424 |
| 42 | MP0002429_abnormal_blood_cell | 1.57038419 |
| 43 | MP0001873_stomach_inflammation | 1.56066165 |
| 44 | MP0002722_abnormal_immune_system | 1.54906285 |
| 45 | MP0002132_abnormal_respiratory_system | 1.54540685 |
| 46 | MP0004381_abnormal_hair_follicle | 1.54420152 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.48011498 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.47872128 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.39425700 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.34143719 |
| 51 | MP0000858_altered_metastatic_potential | 1.29103956 |
| 52 | MP0000343_altered_response_to | 1.29103098 |
| 53 | MP0003787_abnormal_imprinting | 1.25134769 |
| 54 | MP0002933_joint_inflammation | 1.24241368 |
| 55 | MP0003866_abnormal_defecation | 1.21582505 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.18755811 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.18742398 |
| 58 | MP0003075_altered_response_to | 1.16938076 |
| 59 | MP0004883_abnormal_blood_vessel | 1.15363853 |
| 60 | MP0000604_amyloidosis | 1.15106538 |
| 61 | MP0009278_abnormal_bone_marrow | 1.14770278 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.13589387 |
| 63 | MP0003828_pulmonary_edema | 1.10925922 |
| 64 | MP0008260_abnormal_autophagy | 1.09439570 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.09201597 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.09201597 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.06418297 |
| 68 | MP0009763_increased_sensitivity_to | 1.04925317 |
| 69 | MP0001851_eye_inflammation | 1.00849782 |
| 70 | MP0002254_reproductive_system_inflammat | 1.00060372 |
| 71 | MP0010307_abnormal_tumor_latency | 0.99702297 |
| 72 | MP0005166_decreased_susceptibility_to | 0.98318379 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 0.96589205 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.94681146 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.91803360 |
| 76 | MP0002396_abnormal_hematopoietic_system | 0.89333221 |
| 77 | MP0010234_abnormal_vibrissa_follicle | 0.86099799 |
| 78 | MP0003045_fibrosis | 0.85568462 |
| 79 | MP0005023_abnormal_wound_healing | 0.83468888 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.83385604 |
| 81 | MP0005390_skeleton_phenotype | 0.82163574 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.80818124 |
| 83 | MP0003195_calcinosis | 0.79034620 |
| 84 | MP0005174_abnormal_tail_pigmentation | 0.78149900 |
| 85 | MP0003186_abnormal_redox_activity | 0.77951127 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.76531831 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 0.75669966 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.74946200 |
| 89 | MP0002928_abnormal_bile_duct | 0.74041175 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.73996362 |
| 91 | MP0003878_abnormal_ear_physiology | 0.73996362 |
| 92 | MP0000490_abnormal_crypts_of | 0.73960187 |
| 93 | MP0000609_abnormal_liver_physiology | 0.73801850 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.73767162 |
| 95 | MP0003252_abnormal_bile_duct | 0.70074732 |
| 96 | MP0002136_abnormal_kidney_physiology | 0.68941648 |
| 97 | MP0000249_abnormal_blood_vessel | 0.67585748 |
| 98 | MP0005360_urolithiasis | 0.65581757 |
| 99 | MP0003091_abnormal_cell_migration | 0.64439602 |
| 100 | MP0001881_abnormal_mammary_gland | 0.63944999 |
| 101 | MP0005164_abnormal_response_to | 0.63879487 |
| 102 | MP0001663_abnormal_digestive_system | 0.63420023 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.63138210 |
| 104 | MP0002019_abnormal_tumor_incidence | 0.63135587 |
| 105 | MP0003806_abnormal_nucleotide_metabolis | 0.61915109 |
| 106 | MP0002653_abnormal_ependyma_morphology | 0.60867059 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.60634625 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.59514225 |
| 109 | MP0003795_abnormal_bone_structure | 0.58228133 |
| 110 | MP0005083_abnormal_biliary_tract | 0.58040927 |
| 111 | MP0001348_abnormal_lacrimal_gland | 0.57887827 |
| 112 | MP0001501_abnormal_sleep_pattern | 0.56748561 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.56431850 |
| 114 | MP0005319_abnormal_enzyme/_coenzyme | 0.55975656 |
| 115 | MP0002009_preneoplasia | 0.54441205 |
| 116 | MP0004130_abnormal_muscle_cell | 0.53856001 |
| 117 | MP0005451_abnormal_body_composition | 0.52135145 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.51984545 |
| 119 | MP0004484_altered_response_of | 0.51176119 |
| 120 | MP0000371_diluted_coat_color | 0.51155445 |
| 121 | MP0002168_other_aberrant_phenotype | 0.50816508 |
| 122 | MP0000598_abnormal_liver_morphology | 0.50502705 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.50103868 |
| 124 | MP0003690_abnormal_glial_cell | 0.49450233 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.48730733 |
| 126 | MP0008873_increased_physiological_sensi | 0.46879661 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.46713285 |
| 128 | MP0002693_abnormal_pancreas_physiology | 0.46073478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.09030122 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.66849765 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.56575000 |
| 4 | Chronic otitis media (HP:0000389) | 5.52604769 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.09025058 |
| 6 | Myositis (HP:0100614) | 4.73487534 |
| 7 | Nasal polyposis (HP:0100582) | 4.69267155 |
| 8 | Hypochromic microcytic anemia (HP:0004840) | 4.62813841 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.59176134 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.52083783 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.38917598 |
| 12 | Recurrent bronchitis (HP:0002837) | 4.34245369 |
| 13 | Recurrent viral infections (HP:0004429) | 4.23389099 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 4.18009925 |
| 15 | Orchitis (HP:0100796) | 4.16707017 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.08580379 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 4.01599562 |
| 18 | Vasculitis (HP:0002633) | 3.92981076 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.90438024 |
| 20 | Optic neuritis (HP:0100653) | 3.90438024 |
| 21 | Recurrent skin infections (HP:0001581) | 3.89955636 |
| 22 | Hypochromic anemia (HP:0001931) | 3.84400573 |
| 23 | Increased IgM level (HP:0003496) | 3.84397967 |
| 24 | Abnormality of T cell number (HP:0011839) | 3.82157849 |
| 25 | Stomatitis (HP:0010280) | 3.80476137 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.79097891 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.79097891 |
| 28 | T lymphocytopenia (HP:0005403) | 3.69892505 |
| 29 | Pustule (HP:0200039) | 3.53421218 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 3.52770677 |
| 31 | Abnormality of T cells (HP:0002843) | 3.28013913 |
| 32 | Hypergammaglobulinemia (HP:0010702) | 3.24053124 |
| 33 | Interstitial pulmonary disease (HP:0006530) | 3.22840902 |
| 34 | Chronic sinusitis (HP:0011109) | 3.20642615 |
| 35 | Gingivitis (HP:0000230) | 3.16708067 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.15005688 |
| 37 | Obstructive lung disease (HP:0006536) | 3.15005688 |
| 38 | Basal ganglia calcification (HP:0002135) | 3.11093240 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 3.10492917 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98069238 |
| 41 | Meningitis (HP:0001287) | 2.97474891 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.97425805 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.96527666 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.90767615 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.89253861 |
| 46 | Hemoptysis (HP:0002105) | 2.88844196 |
| 47 | Periodontitis (HP:0000704) | 2.82779225 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.80914857 |
| 49 | Leukocytosis (HP:0001974) | 2.79486923 |
| 50 | Increased IgE level (HP:0003212) | 2.79110714 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.77716198 |
| 52 | Episodic fever (HP:0001954) | 2.76791968 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.75649412 |
| 54 | Cellulitis (HP:0100658) | 2.75156689 |
| 55 | Gingival bleeding (HP:0000225) | 2.74464626 |
| 56 | IgM deficiency (HP:0002850) | 2.73373273 |
| 57 | Colitis (HP:0002583) | 2.71228602 |
| 58 | Microcytic anemia (HP:0001935) | 2.70842040 |
| 59 | Joint swelling (HP:0001386) | 2.66689312 |
| 60 | Arterial thrombosis (HP:0004420) | 2.62570726 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.62005044 |
| 62 | Eosinophilia (HP:0001880) | 2.61591819 |
| 63 | Combined immunodeficiency (HP:0005387) | 2.61470780 |
| 64 | Lymphopenia (HP:0001888) | 2.58121203 |
| 65 | Stomach cancer (HP:0012126) | 2.57651856 |
| 66 | IgG deficiency (HP:0004315) | 2.56996191 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56010258 |
| 68 | Severe combined immunodeficiency (HP:0004430) | 2.53953063 |
| 69 | Keratoconjunctivitis sicca (HP:0001097) | 2.53689029 |
| 70 | Panhypogammaglobulinemia (HP:0003139) | 2.52964425 |
| 71 | Urticaria (HP:0001025) | 2.51628527 |
| 72 | Emphysema (HP:0002097) | 2.48291423 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.45663065 |
| 74 | Abnormality of eosinophils (HP:0001879) | 2.44482614 |
| 75 | Anorexia (HP:0002039) | 2.41119636 |
| 76 | Increased cerebral lipofuscin (HP:0011813) | 2.39332996 |
| 77 | Bronchitis (HP:0012387) | 2.38916660 |
| 78 | Keratoconjunctivitis (HP:0001096) | 2.38338860 |
| 79 | Chronic diarrhea (HP:0002028) | 2.35263942 |
| 80 | Encephalitis (HP:0002383) | 2.35054269 |
| 81 | Agammaglobulinemia (HP:0004432) | 2.34457965 |
| 82 | Petechiae (HP:0000967) | 2.32492447 |
| 83 | Peritonitis (HP:0002586) | 2.32083565 |
| 84 | Skin ulcer (HP:0200042) | 2.28128032 |
| 85 | Myocardial infarction (HP:0001658) | 2.26339611 |
| 86 | Granulocytopenia (HP:0001913) | 2.26254254 |
| 87 | Loss of speech (HP:0002371) | 2.23957077 |
| 88 | Porencephaly (HP:0002132) | 2.23312161 |
| 89 | IgA deficiency (HP:0002720) | 2.22962109 |
| 90 | Gastrointestinal stroma tumor (HP:0100723) | 2.22412058 |
| 91 | Recurrent pneumonia (HP:0006532) | 2.22277317 |
| 92 | Sepsis (HP:0100806) | 2.19967269 |
| 93 | Thyroiditis (HP:0100646) | 2.19195765 |
| 94 | Recurrent lower respiratory tract infections (HP:0002783) | 2.16239076 |
| 95 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15793255 |
| 96 | Keratitis (HP:0000491) | 2.15026084 |
| 97 | Cheilitis (HP:0100825) | 2.14522998 |
| 98 | Purpura (HP:0000979) | 2.14261805 |
| 99 | Osteomyelitis (HP:0002754) | 2.14203790 |
| 100 | Epistaxis (HP:0000421) | 2.13594412 |
| 101 | Premature loss of primary teeth (HP:0006323) | 2.13236330 |
| 102 | Acute hepatic failure (HP:0006554) | 2.12574193 |
| 103 | Thick nail (HP:0001805) | 2.12461325 |
| 104 | Hematochezia (HP:0002573) | 2.11530271 |
| 105 | Pulmonary embolism (HP:0002204) | 2.08690681 |
| 106 | Arthralgia (HP:0002829) | 2.07095507 |
| 107 | Chest pain (HP:0100749) | 2.06735274 |
| 108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.06509075 |
| 109 | Glomerulonephritis (HP:0000099) | 2.06428204 |
| 110 | Abnormality of the endocardium (HP:0004306) | 2.06136573 |
| 111 | Thrombocytosis (HP:0001894) | 2.05713940 |
| 112 | Gangrene (HP:0100758) | 2.05159307 |
| 113 | Prostate neoplasm (HP:0100787) | 2.03186259 |
| 114 | Recurrent sinusitis (HP:0011108) | 1.99100324 |
| 115 | Abnormality of B cell number (HP:0010975) | 1.98292080 |
| 116 | Abnormality of the pericardium (HP:0001697) | 1.96445692 |
| 117 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92524726 |
| 118 | Acne (HP:0001061) | 1.92070960 |
| 119 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.89374457 |
| 120 | Skin rash (HP:0000988) | 1.86471512 |
| 121 | Hemiplegia (HP:0002301) | 1.85538531 |
| 122 | Vertigo (HP:0002321) | 1.85443019 |
| 123 | Glomerulopathy (HP:0100820) | 1.84077947 |
| 124 | Alveolar cell carcinoma (HP:0006519) | 1.82725163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TYK2 | 4.26373529 |
| 2 | MAP4K1 | 4.05912604 |
| 3 | MAP3K14 | 3.81149465 |
| 4 | IKBKE | 3.79337732 |
| 5 | TBK1 | 3.62148854 |
| 6 | JAK3 | 3.49182664 |
| 7 | FGFR4 | 3.43995852 |
| 8 | TXK | 3.42710579 |
| 9 | BLK | 3.00656547 |
| 10 | JAK1 | 2.85859328 |
| 11 | TNK2 | 2.58145537 |
| 12 | KIT | 2.56564362 |
| 13 | ERN1 | 2.36371117 |
| 14 | ZAP70 | 2.18243625 |
| 15 | FRK | 2.14832105 |
| 16 | ACVR1B | 2.14042321 |
| 17 | IRAK4 | 2.11749944 |
| 18 | FGFR3 | 2.07607682 |
| 19 | IKBKB | 2.04058061 |
| 20 | RIPK4 | 2.02509715 |
| 21 | MAP3K13 | 1.81901915 |
| 22 | CSK | 1.73357663 |
| 23 | EPHB1 | 1.69097862 |
| 24 | IRAK3 | 1.64426169 |
| 25 | SYK | 1.51081749 |
| 26 | STK10 | 1.50900281 |
| 27 | ITK | 1.47317453 |
| 28 | LCK | 1.44891188 |
| 29 | EPHA3 | 1.41717841 |
| 30 | HCK | 1.38439954 |
| 31 | CHUK | 1.37902556 |
| 32 | NME2 | 1.36743146 |
| 33 | GRK6 | 1.28287543 |
| 34 | BTK | 1.27833136 |
| 35 | PBK | 1.24636222 |
| 36 | NLK | 1.24605548 |
| 37 | PIM2 | 1.20257861 |
| 38 | MST4 | 1.20099068 |
| 39 | TAOK1 | 1.18840869 |
| 40 | TEC | 1.16177803 |
| 41 | JAK2 | 1.13632476 |
| 42 | CSF1R | 1.12308295 |
| 43 | RPS6KA4 | 1.04383873 |
| 44 | PTK2B | 1.03353768 |
| 45 | LYN | 1.02560442 |
| 46 | YES1 | 1.00076202 |
| 47 | MAP3K10 | 0.99148553 |
| 48 | PIM1 | 0.94396851 |
| 49 | MARK3 | 0.93627053 |
| 50 | TAOK3 | 0.91629829 |
| 51 | LRRK2 | 0.89808683 |
| 52 | KDR | 0.88675532 |
| 53 | FES | 0.87785089 |
| 54 | PIK3CG | 0.87650544 |
| 55 | PRKD2 | 0.85426507 |
| 56 | ADRBK2 | 0.84302705 |
| 57 | TGFBR2 | 0.83209544 |
| 58 | MAP2K6 | 0.82650374 |
| 59 | NEK9 | 0.79960797 |
| 60 | PRKCQ | 0.76892556 |
| 61 | TRIB3 | 0.75599987 |
| 62 | BMX | 0.72888571 |
| 63 | IRAK1 | 0.72383418 |
| 64 | FGR | 0.72147205 |
| 65 | CAMKK2 | 0.71606311 |
| 66 | MAP3K7 | 0.70716333 |
| 67 | STK11 | 0.70661350 |
| 68 | RIPK1 | 0.68342055 |
| 69 | PRPF4B | 0.65734244 |
| 70 | DAPK2 | 0.63538152 |
| 71 | MARK2 | 0.61217663 |
| 72 | SIK3 | 0.60795638 |
| 73 | PKN2 | 0.60448969 |
| 74 | PTK6 | 0.58218661 |
| 75 | MAP3K6 | 0.56774781 |
| 76 | OXSR1 | 0.56056913 |
| 77 | IRAK2 | 0.55371764 |
| 78 | MAPK11 | 0.53490668 |
| 79 | GRK7 | 0.53336067 |
| 80 | CDK19 | 0.53143959 |
| 81 | EGFR | 0.52993671 |
| 82 | SIK2 | 0.52768173 |
| 83 | KSR2 | 0.51900334 |
| 84 | PRKCH | 0.51241783 |
| 85 | PRKCD | 0.47198946 |
| 86 | TESK2 | 0.46637883 |
| 87 | CLK1 | 0.46078752 |
| 88 | MATK | 0.45855128 |
| 89 | STK38 | 0.45749328 |
| 90 | EIF2AK2 | 0.45723094 |
| 91 | STK4 | 0.45645719 |
| 92 | ABL1 | 0.45575814 |
| 93 | FLT3 | 0.43611685 |
| 94 | ADRBK1 | 0.43396189 |
| 95 | DYRK1B | 0.43131803 |
| 96 | MAP2K3 | 0.42935508 |
| 97 | MAPK13 | 0.41274577 |
| 98 | PDPK1 | 0.41118675 |
| 99 | MAP3K2 | 0.39999850 |
| 100 | MAPK7 | 0.38376852 |
| 101 | MAPK12 | 0.37893660 |
| 102 | MAP2K4 | 0.37890965 |
| 103 | SIK1 | 0.37533460 |
| 104 | MAP3K5 | 0.37278179 |
| 105 | PRKCZ | 0.36188312 |
| 106 | CDC42BPA | 0.36010054 |
| 107 | RPS6KA5 | 0.35854280 |
| 108 | TESK1 | 0.35511647 |
| 109 | BMPR2 | 0.35131308 |
| 110 | TTN | 0.33201656 |
| 111 | MST1R | 0.33137539 |
| 112 | PDK1 | 0.33074582 |
| 113 | TLK1 | 0.32700808 |
| 114 | MAP2K2 | 0.32405831 |
| 115 | FYN | 0.31785505 |
| 116 | PAK3 | 0.31323662 |
| 117 | ALK | 0.31035432 |
| 118 | MAP3K1 | 0.30922308 |
| 119 | CDK12 | 0.30172813 |
| 120 | SGK2 | 0.28598006 |
| 121 | INSR | 0.28255515 |
| 122 | MAP4K2 | 0.27053792 |
| 123 | ABL2 | 0.26534908 |
| 124 | MAPKAPK2 | 0.25771354 |
| 125 | MAP3K11 | 0.24651677 |
| 126 | PRKG2 | 0.24569350 |
| 127 | CDK4 | 0.24511622 |
| 128 | MAP3K3 | 0.23764604 |
| 129 | IGF1R | 0.23005321 |
| 130 | HIPK2 | 0.22297011 |
| 131 | PDGFRB | 0.21288895 |
| 132 | TGFBR1 | 0.21000691 |
| 133 | ARAF | 0.20323524 |
| 134 | CDK6 | 0.19675990 |
| 135 | MAPK4 | 0.19338043 |
| 136 | SRC | 0.18430000 |
| 137 | STK24 | 0.17450276 |
| 138 | MAPK3 | 0.17201644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16253443 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.05156772 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.95740267 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.93670769 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.84734914 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77276791 |
| 7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.76231692 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.73680121 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67236734 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.63969062 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.61625571 |
| 12 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.48406656 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30673078 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.26207140 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 2.14024625 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 2.09606191 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.06751562 |
| 18 | Malaria_Homo sapiens_hsa05144 | 2.02051022 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.95072907 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91830258 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.91605326 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79816829 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.77545548 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.76105361 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.75049955 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70767210 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70011262 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.69144745 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61074185 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57605014 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54444266 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51247983 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.48786266 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44158707 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.42637135 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42467047 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.41849188 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40791027 |
| 39 | Salmonella infection_Homo sapiens_hsa05132 | 1.37369281 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.34357973 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.30689085 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25024308 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.24370777 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18922090 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98495256 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.98328483 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97373904 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92980027 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91424266 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88485794 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82995937 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82568787 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.81768744 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76435226 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75617752 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70423366 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69090725 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67968821 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66143079 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.64223574 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64109612 |
| 62 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63881718 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62976285 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62902847 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62332456 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61296849 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60871808 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60415314 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58837131 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55743874 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53347177 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.52864393 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49295542 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48500066 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48060329 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47324312 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47096697 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45570878 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43792517 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43585540 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43395062 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43389763 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39990248 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39933259 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39285119 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.38922572 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38463212 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37749959 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37010693 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36509215 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36495056 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35846459 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34624561 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.34398011 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32171735 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32011096 |
| 97 | Proteasome_Homo sapiens_hsa03050 | 0.31975687 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30510130 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.29341989 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.27519902 |
| 101 | Morphine addiction_Homo sapiens_hsa05032 | 0.26636206 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26519446 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.25463416 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24708091 |
| 105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22941548 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21522987 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.20954518 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20298476 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.20209586 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.16049298 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.15882267 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.15074427 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14708863 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.14406838 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14196823 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13870447 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.13165301 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09911458 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.09525511 |
| 120 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.06768496 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.06172381 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.05746091 |
| 123 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.04691210 |

